Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.
Publication
, Journal Article
Reed, SD; Lyman, GH
Published in: Cancer
December 15, 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cancer
DOI
EISSN
1097-0142
Publication Date
December 15, 2012
Volume
118
Issue
24
Start / End Page
6298 / 6299
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Humans
- Gene Expression Profiling
- Cost-Benefit Analysis
- Breast Neoplasms
- 4206 Public health
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Reed, S. D., & Lyman, G. H. (2012). Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model. Cancer, 118(24), 6298–6299. https://doi.org/10.1002/cncr.27665
Reed, Shelby D., and Gary H. Lyman. “Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.” Cancer 118, no. 24 (December 15, 2012): 6298–99. https://doi.org/10.1002/cncr.27665.
Reed SD, Lyman GH. Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model. Cancer. 2012 Dec 15;118(24):6298–9.
Reed, Shelby D., and Gary H. Lyman. “Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.” Cancer, vol. 118, no. 24, Dec. 2012, pp. 6298–99. Pubmed, doi:10.1002/cncr.27665.
Reed SD, Lyman GH. Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model. Cancer. 2012 Dec 15;118(24):6298–6299.
Published In
Cancer
DOI
EISSN
1097-0142
Publication Date
December 15, 2012
Volume
118
Issue
24
Start / End Page
6298 / 6299
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Humans
- Gene Expression Profiling
- Cost-Benefit Analysis
- Breast Neoplasms
- 4206 Public health
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis